GYRE THERAPEUTICS, INC.
live · Yahoo FinanceLimited buying: $1.5K bought (counted up to $5.0M); a CEO among the buyers. Holding it back: routine or plan purchases: 100% of the dollars.
No AI review: it runs from a match score of 40. The pipeline flags above come from the filings alone.
Score, not a recommendation.
same price, one day All 3 purchases were at $0.46 on 2022-02-09. That pattern also occurs in IPO or conversion subscriptions, which are not open-market conviction buying.
Price and insider purchases
Live chart from Yahoo Finance, loaded through this server; our daily closes when it is unavailable.
Loading price history…
How the score adds up
How each input is counted →| Input | Strength | Points |
|---|---|---|
| $1.5K bought (counted up to $5.0M)The dollars the insiders bought, a purchase reported jointly counted once, counted from $131. Each tenfold adds 12.4 points, up to $5.0M; more adds nothing. The bar is empty at $10.0K and full at $5.0M. | 0% | +13 |
| 3 distinct insidersHow many different insiders bought. Each extra insider adds less than the one before (the points follow the log of the count: 4.3 per doubling). The bar is full at 10 insiders. | 48% | +7 |
| A CEO among the buyersWhether the chief executive is among the buyers: 10.6 points when yes. | 100% | +11 |
| Stock 93% below its 1-year high (counted up to 30%)How far the stock had fallen from its highest close of the past year, at the close before the buying. Every 10% of fall adds 1.9 points. A fall beyond 30% adds nothing more. The bar is full at a 30% fall. | 100% | +5 |
| 0 days from first to last purchaseDays between the first and the last purchase. Each day takes off 0.11 points: buying close together keeps more. The bar is empty at 60 days. | 100% | +0 |
| Routine or plan purchases: 100% of the dollars | 0% | -6 |
| Largest buyer: USMAN NASSIM (CEO), 33% of the dollars | 100% | -4 |
| Match scoreA score from 0 to 100 worked out from the dollars bought, the number of insiders, whether a CEO bought, how far the stock had fallen, how spread out the purchases were and how much came from one buyer. Its weights were calibrated on past clusters. It is the default ranking of the lists and it decides which clusters get the AI review. It describes the buying; it is not a forecast. | 26 | |
| Pipeline flagsPoints taken off because the filings themselves show this buying was an offering, a plan or a 10b5-1 programme. Used only when there is no AI review; from Form 4 footnotes, 8-K filings and prices. (IPO or offering) | -14 | |
| Insider ScoreThe number from 0 to 100 shown on each cluster and used to rank the lists. By default it is the match score, plus the points of the AI review when there is one. It describes the buying; it is not a forecast or a recommendation. | 12 | |
Why are they buying?
No AI review: it runs only on clusters with a match score of 40 or more. The filings in the table below are the primary evidence.
| Date | InsiderAn officer or director of a company, or an owner of more than 10% of its shares. The law requires them to report their trades in the company's stock to the SEC. | Role | Shares | Price | Value | Flags | Filing |
|---|---|---|---|---|---|---|---|
| 2022-02-09 | Blouse Grant E. history of Blouse Grant E.'s purchases | Other C-suite | 3,250 | $0.46 | $1.5K | SEC filing for Blouse Grant E. (opens in a new tab) | |
| 2022-02-09 | Miller Seline E. history of Miller Seline E.'s purchases | CFO | 3,250 | $0.46 | $1.5K | SEC filing for Miller Seline E. (opens in a new tab) | |
| 2022-02-09 | USMAN NASSIM 3 purchases with a 63-day result · median -0.3% | CEO | 3,250 | $0.46 | $1.5K | SEC filing for USMAN NASSIM (opens in a new tab) | |
| Total | $4.5K | ||||||
Other buying runs at GYRE
A buying runPurchases at one company with no pause longer than the cluster rule allows. A long pause ends the run, so one company can have several. ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmarkThe index a stock's return is compared with: a small-cap index for small companies, a large-cap index otherwise. (IWM for small companies, SPY otherwise), from the first open after the buying run became a cluster. Past results, not a forecast.
After this buying run became a cluster, vs benchmark: 21 days +25.2% (+25.6% raw)63 days -14.8% (-28.3% raw)126 days +272.3% (+266.0% raw)
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2022-08-09 | 3 | $4.6K | 12 | +13.1% (+5.4% raw) | +19.3% (+13.7% raw) | -11.6% (-13.1% raw) | closed |
| 2021-08-09 | 3 | $9.7K | 21 | +11.3% (+10.7% raw) | -36.0% (-27.5% raw) | -80.0% (-86.8% raw) | closed |
| 2020-02-25 → 2020-03-16 | 6 | $74.2K | 56 | +18.5% (+27.3% raw) | +65.4% (+99.2% raw) | -20.5% (+21.8% raw) | closed |